Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

23.1%

3 terminated/withdrawn out of 13 trials

Success Rate

76.9%

-9.6% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

NCT04241718Not ApplicableTerminated

A Feasibility Study on Ultrafiltration and Blood Volume Measurements

Role: collaborator

NCT03340116Withdrawn

Measurement of Blood Volume Loss During Burn Surgery

Role: collaborator

NCT06227819Completed

BVA-200 vs BVA-100 Validation Study

Role: lead

NCT04855097Not ApplicableCompleted

Evaluation of Blood Volume Analysis- Guided Management of Decompensated Heart Failure

Role: lead

NCT04660396Completed

Monitoring Outpatient Blood VolumE in Heart Failure

Role: lead

NCT04517695Completed

Blood Volume Assessment in COVID-19 and Bacterial Sepsis

Role: collaborator

NCT04111185Not ApplicableCompleted

Daxor - Blood Volume Analysis

Role: collaborator

NCT00861770Not ApplicableCompleted

Utilizing Blood Volume Measurements in the Treatment of Heart Failure Patients

Role: collaborator

NCT02717533Completed

Blood Volume Analysis and Renal Outcomes in Hemodialysis

Role: collaborator

NCT01001312Phase 4Terminated

Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure

Role: collaborator

NCT01679249Completed

Blood Volume Analysis and Related Outcomes in Hemodialysis

Role: collaborator

NCT01542749Completed

Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer

Role: lead

NCT00660608Completed

Conservation of Red Cell Mass , Oxygen Supply and Demand in Cardiac Surgery

Role: collaborator

All 13 trials loaded